Digital System Aims to Revolutionize Sarcopenia Diagnosis and Treatment

Sarcopenia, a progressive and generalized skeletal muscle disorder, is characterized by loss of muscle mass, strength, and physical performance, leading to increased risk of falls, frailty, and mortality. Current diagnostic and treatment approaches for sarcopenia are often fragmented and reactive, highlighting a critical need for an integrated, proactive, and digitally-driven system for early warning, intervention, and prevention.

As this study is currently recruiting, no direct results are available yet. However, the research aims to establish a robust framework for sarcopenia management, with the digital vaccine component expected to significantly improve early detection rates. The digital drug and digital rehabilitation interventions are designed to provide personalized, pathogenesis-associated treatments and preventive strategies, aiming for measurable improvements in muscle mass, strength, and physical function in at-risk individuals and those with existing muscle atrophy. The overarching goal is to create a digital visual tertiary prevention network for sarcopenia, aiming to reduce its prevalence and impact across a large population. The longitudinal monitoring of 10000 participants over 5 years is intended to provide extensive data to validate the effectiveness of these integrated digital tools.